UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Thyroid Stimulating Hormone circadian variations in paranoid schizophrenic psychosis between acute and stable phases. A comparative study

European psychiatry, 2023-03, Vol.66 (S1), p.S186-S186

2023

Volltextzugriff (PDF)

Daytime/nighttime levels of serum IL-33 in schizophrenia at hospital admission and before discharge

European psychiatry, 2023-03, Vol.66 (S1), p.S1062-S1063

2023

Volltextzugriff (PDF)

Night-time/daytime Protein S100B serum levels in paranoid schizophrenic patients

European psychiatry, 2023-03, Vol.66 (S1), p.S445-S446

2023

Volltextzugriff (PDF)

Anorexia nervosa and Wernicke-Korsakoff syndrome: case report an literature review

European psychiatry, 2023-03, Vol.66 (S1), p.S424-S424

2023

Volltextzugriff (PDF)

Nalmefene as an intermittent treatment for alcohol abuse triggering cocaine and sex consumption

European psychiatry, 2016-03, Vol.33 (S1), p.S309-S309

2016

Volltextzugriff (PDF)

Acute paranoid schizophrenia patients present higher serum S100B protein levels at admission than at discharge

European neuropsychopharmacology, 2016-10, Vol.26, p.S587-S588

2016

Volltextzugriff (PDF)

Can we maintain plasma clozapine levels above the upper limit?

European neuropsychopharmacology, 2016-10, Vol.26, p.S559-S559

2016

Volltextzugriff (PDF)

Introversion/extraversion Does Not Affect Serum Melatonin Levels

European psychiatry, 2015-03, Vol.30, p.396-396

2015

Volltextzugriff (PDF)

P.3.f.022 Serum total antioxidant capacity concentrations in paranoid schizophrenia. A case control study

European neuropsychopharmacology, 2013-10, Vol.23, p.S504-S504

2013

Volltextzugriff (PDF)

P.8.b.021 Respiratory improvement in chronic asthma treated with autogenic therapy

European neuropsychopharmacology, 2014-10, Vol.24, p.S745-S746

2014

Volltextzugriff (PDF)

Secondary Mania and Tapentadol

European psychiatry, 2015-03, Vol.30, p.1604-1604

2015

Volltextzugriff (PDF)

EPA-0308 – Suicide rates and economic crisis in spain

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

1177 – Day/night cortisol rhythm in healthy subjects

European psychiatry, 2013, Vol.28, p.1-1

2013

Volltextzugriff (PDF)

EPA-0289 – Psychopathology sex differences in asthmatics

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

P-902 - Depression caused by primary hyperparathyroidism with hypercalcemia: a case report

European psychiatry, 2012, Vol.27, p.1-1

2012

Volltextzugriff (PDF)

EPA-0294 – Can alpha 1 glycoproptein be considered as a marker of negative symptoms in schizophrenia patients?

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

EPA-0048 - Relationships between serum total antioxidant capacity and typical/atypical antipsychotic treatment in acute paranoid schizophrenia

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

Relationship between circadian rhythm and Malondialdehyde serum levels in acute and stabilized schizophrenic patients

European psychiatry, 2024-08, Vol.67 (S1), p.S759-S759

2024

Volltextzugriff (PDF)

757 – Individual items scores vs. total scores of the schizophrenia syndrome on purpose of the relationships with the total antioxidant capacity

European psychiatry, 2013, Vol.28, p.1-1

2013

Volltextzugriff (PDF)

P-778 - S100B Serum protein does not have a circadian rhythm in healthy subjects

European psychiatry, 2012, Vol.27, p.1-1

2012

Volltextzugriff (PDF)

P-777 - Body mass index and S100B serum protein levels are not related in healthy adult subjects

European psychiatry, 2012, Vol.27, p.1-1

2012

Volltextzugriff (PDF)

P03-222 - Predictive Models of Metabolic Syndrome for Patients with Schizophrenic or Bipolar Disorders

European psychiatry, 2011, Vol.26, p.1391-1391

2011

Volltextzugriff (PDF)

P03-287 - Conceptual disorganisation in paranoid schizophrenia inpatients and blood melatonin levels

European psychiatry, 2011, Vol.26, p.1456-1456

2011

Volltextzugriff (PDF)

P03-317 - Agomelatine facilitates benzodiazepine discontinuation in schizophrenia with severe insomnia

European psychiatry, 2010, Vol.25 (S1), p.932-932, Article 25-E923

2010

Volltextzugriff (PDF)

P.1.b.002 Night-time/daytime and daytime/daytime patterns of melatonin levels

European neuropsychopharmacology, 2009, Vol.19, p.S241-S242

2009

Volltextzugriff (PDF)

1 – 25 von 519

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(419)
Mit Volltextzugriff
(375)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Internal Medicine
(56)
Life Sciences & Biomedicine
(48)
Psychiatry
(48)
Humans
(37)
Female
(29)
Surgery
(29)
Male
(26)
Pediatrics
(22)
Medicine, General & Internal
(21)
Adult
(18)
Middle Aged
(17)
Health Care Sciences & Services
(15)
Aged
(12)
Infectious Diseases
(11)
Public, Environmental & Occupational Health
(11)
Nutrition & Dietetics
(10)
Rheumatology
(10)
Adolescent
(9)
Dentistry, Oral Surgery & Medicine
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Thyroid Stimulating Hormone circadian variations in paranoid schizophrenic psychosis between acute and stable phases. A comparative study

Daytime/nighttime levels of serum IL-33 in schizophrenia at hospital admission and before discharge

Night-time/daytime Protein S100B serum levels in paranoid schizophrenic patients

Anorexia nervosa and Wernicke-Korsakoff syndrome: case report an literature review

Nalmefene as an intermittent treatment for alcohol abuse triggering cocaine and sex consumption

Acute paranoid schizophrenia patients present higher serum S100B protein levels at admission than at discharge

Can we maintain plasma clozapine levels above the upper limit?

Introversion/extraversion Does Not Affect Serum Melatonin Levels

P.3.f.022 Serum total antioxidant capacity concentrations in paranoid schizophrenia. A case control study

P.8.b.021 Respiratory improvement in chronic asthma treated with autogenic therapy

Secondary Mania and Tapentadol

EPA-0308 – Suicide rates and economic crisis in spain

1177 – Day/night cortisol rhythm in healthy subjects

EPA-0289 – Psychopathology sex differences in asthmatics

P-902 - Depression caused by primary hyperparathyroidism with hypercalcemia: a case report

EPA-0294 – Can alpha 1 glycoproptein be considered as a marker of negative symptoms in schizophrenia patients?

EPA-0048 - Relationships between serum total antioxidant capacity and typical/atypical antipsychotic treatment in acute paranoid schizophrenia

Relationship between circadian rhythm and Malondialdehyde serum levels in acute and stabilized schizophrenic patients

757 – Individual items scores vs. total scores of the schizophrenia syndrome on purpose of the relationships with the total antioxidant capacity

P-778 - S100B Serum protein does not have a circadian rhythm in healthy subjects

P-777 - Body mass index and S100B serum protein levels are not related in healthy adult subjects

P03-222 - Predictive Models of Metabolic Syndrome for Patients with Schizophrenic or Bipolar Disorders

P03-287 - Conceptual disorganisation in paranoid schizophrenia inpatients and blood melatonin levels

P03-317 - Agomelatine facilitates benzodiazepine discontinuation in schizophrenia with severe insomnia

P.1.b.002 Night-time/daytime and daytime/daytime patterns of melatonin levels

Suchergebnisse filtern